 Connection
Ihab Kamel to Liver Cirrhosis
This is a "connection" page, showing publications Ihab Kamel has written about Liver Cirrhosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.050 |
|
|
|
-
Rezvani Habibabadi R, Khoshpouri P, Ghadimi M, Shaghaghi M, Ameli S, Hazhirkarzar B, Pandey P, Aliyari Ghasabeh M, Pandey A, Kamel IR. Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography. Eur Radiol. 2020 Mar; 30(3):1609-1615.
Score: 0.518
-
Bonekamp D, Bonekamp S, Ou HY, Torbenson MS, Corona-Villalobos CP, Mezey E, Kamel IR. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging. J Magn Reson Imaging. 2014 Nov; 40(5):1137-46.
Score: 0.343
-
Ou HY, Bonekamp S, Bonekamp D, Corona-Villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. AJR Am J Roentgenol. 2013 Oct; 201(4):W596-602.
Score: 0.339
-
Bonekamp D, Bonekamp S, Geiger B, Kamel IR. An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis. J Comput Assist Tomogr. 2012 Nov-Dec; 36(6):681-9.
Score: 0.318
-
Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):885-92.
Score: 0.297
-
Borhani A, Luu H, Mohseni A, Xu Z, Shaghaghi M, Tolosa C, Attari MMA, Madani SP, Shahbazian H, Khoshpouri P, Afyouni S, Zandieh G, Kamel IR, Kim AK. Screening for exclusion of high-risk bleeding features of esophageal varices in cirrhosis through CT and MRI. Clin Imaging. 2024 Jun; 110:110168.
Score: 0.177
-
Madani SP, Mirza-Aghazadeh-Attari M, Mohseni A, Pawlik T, Kamel IR. Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations. J Surg Oncol. 2023 Mar; 127(3):385-393.
Score: 0.160
-
Ghadimi M, Habibabadi RR, Hazhirkarzar B, Shaghaghi M, Ameli S, Khoshpouri P, Ghasabeh MA, Gurakar A, Pawlik TM, Kamel IR. Advances in Imaging of Diffuse Parenchymal Liver Disease. J Clin Gastroenterol. 2020 09; 54(8):682-695.
Score: 0.137
-
Khoshpouri P, Habibabadi RR, Hazhirkarzar B, Ameli S, Ghadimi M, Ghasabeh MA, Menias CO, Kim A, Li Z, Kamel IR. Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up. Radiographics. 2019 Nov-Dec; 39(7):1938-1964.
Score: 0.129
-
Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, McNamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol. 2017 Nov; 14(11S):S391-S405.
Score: 0.113
-
Pandey P, Pandey A, Dillhoff M, Schmidt C, Kamel IR, Pawlik TM. Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy. J Gastrointest Surg. 2018 02; 22(2):344-360.
Score: 0.112
-
Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, McNamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol. 2017 May; 14(5S):S103-S117.
Score: 0.109
-
Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol. 2009 Jan; 50(1):17-35.
Score: 0.060
-
Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005 Feb; 19(1):63-89.
Score: 0.047
-
Towbin AJ, Ye W, Huang S, Karmazyn BW, Molleston JP, Masand P, Leung DH, Chang S, Narkewicz MR, Alazraki AL, Freeman AJ, Otto RK, Green N, Kamel IR, Karnsakul WW, Magee JC, Tkach J, Palermo JJ. Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
Score: 0.042
-
Brown ZJ, Baghdadi A, Kamel I, Labiner HE, Hewitt DB, Pawlik TM. Diagnosis and management of choledochal cysts. HPB (Oxford). 2023 01; 25(1):14-25.
Score: 0.040
-
Kamel IR, Bluemke DA. Imaging evaluation of hepatocellular carcinoma. J Vasc Interv Radiol. 2002 Sep; 13(9 Pt 2):S173-84.
Score: 0.039
-
Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol. 2020 May; 17(5S):S70-S80.
Score: 0.033
-
Kim B, Woreta T, Chen PH, Limketkai B, Singer A, Dagher N, Cameron A, Lin MT, Kamel I, Gurakar A. Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature. Dig Dis Sci. 2013 May; 58(5):1185-90.
Score: 0.020
-
Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM. Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg. 2011 Nov; 15(11):2089-97.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|